These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 16394109)

  • 1. Leukocyte recruitment and vascular injury in diabetic nephropathy.
    Galkina E; Ley K
    J Am Soc Nephrol; 2006 Feb; 17(2):368-77. PubMed ID: 16394109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.
    Chow FY; Nikolic-Paterson DJ; Ozols E; Atkins RC; Tesch GH
    J Am Soc Nephrol; 2005 Jun; 16(6):1711-22. PubMed ID: 15857924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.
    Ichinose K; Kawasaki E; Eguchi K
    Am J Nephrol; 2007; 27(6):554-64. PubMed ID: 17823503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
    Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
    Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of renal inflammation: therapeutic strategies.
    Karkar A
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):1-19. PubMed ID: 18087117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature.
    Wagner JG; Roth RA
    Pharmacol Rev; 2000 Sep; 52(3):349-74. PubMed ID: 10977867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
    Rivero A; Mora C; Muros M; García J; Herrera H; Navarro-González JF
    Clin Sci (Lond); 2009 Mar; 116(6):479-92. PubMed ID: 19200057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial interaction of leukocytes within the microvasculature: deformability, adhesion, and transmigration.
    Downey GP; Fialkow L; Fukushima T
    New Horiz; 1995 May; 3(2):219-28. PubMed ID: 7583163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines and tissue injury.
    Furie MB; Randolph GJ
    Am J Pathol; 1995 Jun; 146(6):1287-301. PubMed ID: 7778669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanisms of post-adhesive transmigration of T cells.
    Masuyama J
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):121-7. PubMed ID: 11348016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.
    Navarro JF; Mora-Fernández C
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):441-50. PubMed ID: 17113815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine reduces leukocyte migration through different mechanisms in spontaneously hypertensive and normotensive rats.
    Rodrigues SF; de Oliveira MA; dos Santos RA; Soares AG; de Cássia Tostes R; Carvalho MH; Fortes ZB
    Eur J Pharmacol; 2008 Jul; 589(1-3):206-14. PubMed ID: 18554582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular mechanisms of venous leg ulcers development--the "puzzle" theory.
    Simka M
    Int Angiol; 2010 Feb; 29(1):1-19. PubMed ID: 20224526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy.
    Wong CK; Ho AW; Tong PC; Yeung CY; Kong AP; Lun SW; Chan JC; Lam CW
    Clin Exp Immunol; 2007 Jul; 149(1):123-31. PubMed ID: 17425653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucocyte recruitment under fluid shear: mechanical and molecular regulation within the inflammatory synapse.
    Simon SI; Sarantos MR; Green CE; Schaff UY
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):217-24. PubMed ID: 19018799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Han SY; Kim CH; Kim HS; Jee YH; Song HK; Lee MH; Han KH; Kim HK; Kang YS; Han JY; Kim YS; Cha DR
    J Am Soc Nephrol; 2006 May; 17(5):1362-72. PubMed ID: 16571782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy.
    Ha H; Hwang IA; Park JH; Lee HB
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S42-5. PubMed ID: 18845352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental models to investigate inflammatory processes in chronic venous insufficiency.
    Korthuis RJ; Unthank JL
    Microcirculation; 2000; 7(6 Pt 2):S13-22. PubMed ID: 11151966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry of inflammatory processes and vascular injury. Role of neutrophils: a review.
    Belova LA
    Biochemistry (Mosc); 1997 Jun; 62(6):563-70. PubMed ID: 9284536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.